Total (n = 147) | UV (n = 46) | PV (n = 28) | FV (n = 73) | P | |
---|---|---|---|---|---|
Gender | 0.524 | ||||
Male, No. (%) | 65 (44.2) | 20 (43.5) | 15 (53.6) | 30 (41.1) | |
Female, No. (%) | 82 (55.8) | 26 (56.5) | 13 (46.4) | 43 (58.9) | |
Age, years | 53 (35–61) | 55.5 (32.5–69.25) | 57 (38.5–65) | 47 (35.5–58) | 0.069 |
BMI, kg/m2 | 22.2 (20.83–24.74) | 21.88 (20.74–24.77) | 22.69 (20.61–24.72) | 22.2 (20.9–24.56) | 0.885 |
Current Smoking, No. (%) | 61 (41.5) | 18 (39.1) | 14 (50) | 29 (39.7) | 0.596 |
Symptoms | |||||
Fever, No. (%) | 45 (30.6) | 12 (26.1) | 9 (32.1) | 24 (32.9) | 0.722 |
Cough, No. (%) | 63 (42.9) | 19 (41.3) | 11 (39.3) | 33 (45.2) | 0.837 |
Diarrhea, No. (%) | 6 (4.1) | 2 (4.3) | 1 (3.6) | 3 (4.1) | |
Sore throat, No. (%) | 23 (15.6) | 5 (10.9) | 5 (17.9) | 13 (17.8) | 0.561 |
Chills, No. (%) | 1 (0.7) | 0 | 1 (3.6) | 0 | |
Abdominal pain, No. (%) | 1 (0.7) | 1 (2.2) | 0 | 0 | |
Loss of smell, No. (%) | 3 (2) | 0 | 1 (3.6) | 2 (2.7) | |
Loss of taste, No. (%) | 2 (1.4) | 0 | 0 | 2 (2.7) | |
Muscle pains, No. (%) | 4 (2.7) | 3 (6.5) | 1 (3.6) | 0 | |
Loss of appetite, No. (%) | 2 (1.4) | 1 (2.2) | 0 | 1 (1.4) | |
Dizziness, No. (%) | 1 (0.7) | 1 (2.2) | 0 | 0 | |
Fatigue, No. (%) | 13 (8.8) | 4 (8.7) | 6 (21.4) | 3 (4.1) | 0.023 |
Stuffy nose, No. (%) | 12 (8.2) | 4 (8.7) | 1 (3.6) | 7 (9.6) | 0.606 |
Runny nose, No. (%) | 11 (7.5) | 3 (6.5) | 2 (7.1) | 6 (8.2) | 0.940 |
Chest tightness, No. (%) | 1 (0.7) | 1 (2.2) | 0 | 0 | |
Headache, No. (%) | 3 (2) | 2 (4.3) | 1 (3.6) | 0 | |
Asymptomatic, No. (%) | 26 (17.7) | 10 (21.7) | 5 (17.9) | 11 (15.1) | 0.649 |
Comorbidities, No. (%) | 54 (36.7) | 22 (47.8) | 13 (46.4) | 19 (26) | 0.028 |
Hypertension, No. (%) | 40 (27.2) | 16 (34.8) | 10 (35.7) | 14 (19.2) | 0.094 |
Diabetes, No. (%) | 10 (6.8) | 4 (8.7) | 1 (3.6) | 5 (6.9) | |
Coronary heart disease, No. () | 9 (6.1) | 4 (8.7) | 1 (3.6) | 4 (5.5) | |
Chronic pulmonary disease, No. (%) | 3 (2) | 1 (2.2) | 1 (3.6) | 1 (1.4) | |
Chronic liver disease, No. (%) | 1 (0.7) | 0 | 0 | 1 (1.4) | |
Cancer, No. (%) | 2 (1.4) | 1 (2.2) | 1 (3.6) | 0 | |
Chronic kidney disease, No. (%) | 2 (1.4) | 1 (2.2) | 1 (3.6) | 0 | |
Hypothyroidism, No. (%) | 1 (0.7) | 1 (2.2) | 0 | 0 | |
Rheumatoid Arthritis, No. (%) | 1 (0.7) | 1 (2.2) | 0 | 0 | |
History of cerebral hemorrhage, No. (%) | 2 (1.4) | 1 (2.2) | 0 | 1 (1.4) | |
Arrhythmia, No. (%) | 2 (1.4) | 1 (2.2) | 1 (3.6) | 0 | |
Complications | 32 (21.8) | 15 (32.6) | 5 (17.9) | 12 (16.4) | 0.098 |
Liver dysfunction, No. (%) | 49 (33.3) | 19 (41.3) | 6 (21.4) | 24 (32.9) | 0.211 |
Renal dysfunction, No. (%) | 55 (37.4) | 21 (45.7) | 11 (39.3) | 23 (31.5) | 0.292 |
Treatment | |||||
Thymosin α1, No. (%) | 32 (21.8) | 7 (15.2) | 5 (17.9) | 20 (27.4) | 0.250 |
Days from illness onset to hospital admission | 2 (1–3) | 2 (1–3) | 2.5 (1–4) | 2 (1–3) | 0.336 |
Ct value | 29.48 ± 5.99 | 27.84 ± 5.44 | 29.48 ± 6.55 | 30.52 ± 5.94 | 0.057 |